Collectively, these results confirm associations of hepcidin with several biomarkers of inflammation, hypovolemia, and nutritional status and highlight the possibility that hepcidin may be a potential marker of maternal–fetal well-being when infections, inflammation, and malnutrition co-exist. The gene discussed is HAMP; the disease is infection.